Abstract:Renal function and continence of urine are critically dependent on the proper function of the urinary bladder, which stores urine at low pressure and expels it with a precisely orchestrated contraction. A number of congenital and acquired urological anomalies including posterior urethral valves, benign prostatic hyperplasia, and neurogenic bladder secondary to spina bifida/spinal cord injury can result in pathologic tissue remodeling leading to impaired compliance and reduced capacity(1). Functional or anatomical obstruction of the urinary tract is frequently associated with these conditions, and can lead to urinary incontinence and kidney damage from increased storage and voiding pressures(2). Surgical implantation of gastrointestinal segments to expand organ capacity and reduce intravesical pressures represents the primary surgical treatment option for these disorders when medical management fails(3). However, this approach is hampered by the limitation of available donor tissue, and is associated with significant complications including chronic urinary tract infection, metabolic perturbation, urinary stone formation, and secondary malignancy(4,5). Current research in bladder tissue engineering is heavily focused on identifying biomaterial configurations which can support regeneration of tissues at defect sites. Conventional 3-D scaffolds derived from natural and synthetic polymers such as small intestinal submucosa and poly-glycolic acid have shown some short-term success in supporting urothelial and smooth muscle regeneration as well as facilitating increased organ storage capacity in both animal models and in the clinic(6,7). However, deficiencies in scaffold mechanical integrity and biocompatibility often result in deleterious fibrosis(8), graft contracture(9), and calcification(10), thus increasing the risk of implant failure and need for secondary surgical procedures. In addition, restoration of normal voiding characteristics utilizing standard biomaterial constructs for augmentation cystoplasty has yet to be achieved, and therefore research and development of novel matrices which can fulfill this role is needed. In order to successfully develop and evaluate optimal biomaterials for clinical bladder augmentation, efficacy research must first be performed in standardized animal models using detailed surgical methods and functional outcome assessments. We have previously reported the use of a bladder augmentation model in mice to determine the potential of silk fibroin-based scaffolds to mediate tissue regeneration and functional voiding characteristics.(11,12) Cystometric analyses of this model have shown that variations in structural and mechanical implant properties can influence the resulting urodynamic features of the tissue engineered bladders(11,12). Positive correlations between the degree of matrix-mediated tissue regeneration determined histologically and functional compliance and capacity evaluated by cystometry were demonstrated in this model(11,12). These results therefore suggest that functional evaluations of biomaterial configurations in rodent bladder augmentation systems may be a useful format for assessing scaffold properties and establishing in vivo feasibility prior to large animal studies and clinical deployment. In the current study, we will present various surgical stages of bladder augmentation in both mice and rats using silk scaffolds and demonstrate techniques for awake and anesthetized cystometry.

Comparison of morphological and functional restoration between asymmetric bilayer chitosan and bladder acellular matrix graft for bladder augmentation in a rat model

Trilayer Three-Dimensional Hydrogel Composite Scaffold Containing Encapsulated Adipose-Derived Stem Cells Promotes Bladder Reconstruction Via SDF-1α/CXCR4 Pathway.

Adipose-derived Stem Cells-Seeded Bladder Acellular Matrix Graft-Silk Fibroin Enhances Bladder Reconstruction in a Rat Model

Time-dependent Bladder Tissue Regeneration Using Bilayer Bladder Acellular Matrix Graft-Silk Fibroin Scaffolds in a Rat Bladder Augmentation Model.

Adipose-derived stem-cell-implanted poly(ϵ-caprolactone)/chitosan scaffold improves bladder regeneration in a rat model

Adipose-Derived Stem-Cell-Implanted Poly(Epsilon-Caprolactone)/Chitosan Scaffold Improves Bladder Regeneration In A Rat Model

Evaluation of Composite Biomaterial Collagen/Chitosan and Polyvinyl Alcohol/Sericin As Tissue Engineering Scaffold in Rat Bladder Augmentation

A Lipid-Nanosphere-Small MyoD Activating RNA-Bladder Acellular Matrix Graft Scaffold [NP(saMyoD)/BAMG] Facilitates Rat Injured Bladder Muscle Repair and Regeneration [NP(saMyoD)/BAMG]

Evaluation of biomaterials for bladder augmentation using cystometric analyses in various rodent models

A Study on the Repair of Bladder by Pro-Producing Bladder Acellular Matrix Graft-Silk Fibroin in Rats

Ex vivo functional evaluation of isolated strips in BAMG tissue-engineered bladders

The morphological regeneration and functional restoration of bladder defects by a novel scaffold and adipose-derived stem cells in a rat augmentation model

Biomimetic Multilayer Scaffolds with Prolonged Retention of Stem Cells-Recruiting and Angiogenic Peptides for Promoting Bladder Regeneration

The enhanced angiogenesis effect of VEGF-silk fibroin nanospheres-BAMG scaffold composited with adipose derived stem cells in a rabbit model

The performance of silk scaffolds in a rat model of augmentation cystoplasty

VEGF-Loaded Nanoparticle-Modified Bacterial Cellulose Combined with Multiple Cells in Tissue-Engineered Bladder

Construction of Tissue-Engineered Bladder Scaffolds with Composite Biomaterials

Coadministration of Platelet-Derived Growth Factor-Bb and Vascular Endothelial Growth Factor with Bladder Acellular Matrix Enhances Smooth Muscle Regeneration and Vascularization for Bladder Augmentation in a Rabbit Model.

Electrostimulation-Based Decellularized Matrix Bladder Patch Promotes Bladder Repair in Rats

Tissue Performance of Bladder Following Stretched Electrospun Silk Fibroin Matrix and Bladder Acellular Matrix Implantation in a Rabbit Model

A biodegradable microgrooved and tissue mechanocompatible citrate-based scaffold improves bladder tissue regeneration